Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23722658 | 0.91 | ALDH1A1 (0.33) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL28692800 | 0.87 | KMT2A (0.37) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL5352784 | 0.80 | ALDH1A1 (0.36) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL38870 | 0.76 | ALDH1A1 (0.44) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL10905515 | 0.76 | ALDH1A1 (0.43) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL29439072 | 0.76 | ALDH1A1 (0.44) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| Pyrene SCHEMBL5535765 | 0.75 | PSMB8 (0.38) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL5355184 | 0.75 | ALDH1A1 (0.36) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL15389891 | 0.74 | ALDH1A1 (0.42) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| Succinimide SCHEMBL28533922 | 0.74 | ALDH1A1 (0.36) | KDM4EALDH1A1HPGDMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1949 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210275693-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC. | 2021-09-09 | — | — | US | claimed |
| US-10961571-B2 | Polymerase assay with a FRET substrate | Life Technologies Corporation (US) | 2021-03-30 | — | — | US | claimed |
| US-20190307904-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC (US) | 2019-10-10 | — | — | US | claimed |
| EP-3541960-A2 | METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS | Quest Diagnostics Investments LLC (US) | 2019-09-25 | — | — | EP | claimed |
| US-20190276904-A1 | METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2019-09-12 | — | — | US | claimed |
| US-10301674-B2 | Polymerase assay with a FRET substrate | Life Technologies Corporation (US) | 2019-05-28 | — | — | US | claimed |
| US-20190078133-A1 | DETECTION AND IDENTIFICATION OF BACTERIA AND DETERMINATION OF ANTIBIOTIC SUSCEPTIBILITY USING BACTERIOPHAGE AND REPORTER MOLECULES | CHARLES STARK DRAPER LABORATORY INC (US) | 2019-03-14 | — | — | US | claimed |
| WO-2019051106-A1 | DETECTION AND IDENTIFICATION OF BACTERIA AND DETERMINATION OF ANTIBIOTIC SUSCEPTIBILITY USING BACTERIOPHAGE AND REPORTER MOLECULES | THE CHARLES STARK DRAPER LABORATORY INC. (US) | 2019-03-14 | — | — | WO | claimed |
| US-20180136211-A1 | METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2018-05-17 | — | — | US | claimed |
| EP-1427854-A1 | METHODS FOR QUANTIFYING NUCLEAR RUN-ON TRANSCRIPTIONAL ASSAYS | Benitec Australia Ltd. (AU) | 2004-06-16 | — | — | EP | claimed |
| WO-2003018832-A1 | METHODS FOR QUANTIFYING NUCLEAR RUN-ON TRANSCRIPTIONAL ASSAYS | BENITEC AUSTRALIA LTD (AU) | 2003-03-06 | — | — | WO | claimed |
| EP-4399327-A1 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | Becton, Dickinson and Company (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240229117-A1 | MULTIPLEXED PROTEIN AND NUCLEIC ACID DETECTION METHOD WITH ROLLING CIRCLE AMPLIFICATION (RCA) ASSISTED COLOR COMBINATORIAL AND SEQUENTIAL FLUORESCENCE IN SITU HYBRIDIZATION (CCS-FISH) | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-07-11 | — | — | US | disclosed |
| WO-2024148227-A2 | LAMP DETECTION OF AFRICAN SWINE FEVER VIRUS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2024-07-11 | — | — | WO | disclosed |
| US-20240229137-A9 | Oligonucleotide-Comprising Cellular Component-Binding Reagents and Methods of Using the Same | BECTON, DICKINSON AND COMPANY | 2024-07-11 | — | — | US | disclosed |
| US-6271002-B1 | A POLYMERASE CHAIN REACTION KIT FOR INCORPORATING AN RNA POLYMERASE PROMOTER INTO DOUBLE STRANDED CDNA BY AMPLIFICATION WITH AN RNA PRIMER FOR LESS THAN 20 CYCLES; THEN THE RNA POLYMERASE CONTAINING CDNA IS THEN TRANSCRIBED INTO RNA | ROSETTA INPHARMATICS, INC. | 2001-08-07 | — | — | US | disclosed |
| WO-2001038570-A1 | OLIGONUCLEOTIDES AND ASSEMBLIES THEREOF USEFUL IN THE DETECTION OF THE PRESENCE OR ABSENCE OF TARGET NUCLEIC ACID SEQUENCES IN A SAMPLE | GAMIDA SENSE DIAGNOSTICS LTD. (IL) | 2001-05-31 | — | — | WO | disclosed |
| WO-2001016375-A2 | HIGH SPEED PARALLEL MOLECULAR NUCLEIC ACID SEQUENCING | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-03-08 | — | — | WO | disclosed |
| WO-2000050643-A2 | METHOD FOR DETECTING RADIATION EXPOSURE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2000-08-31 | — | — | WO | disclosed |
| US-6090552-A | DETECTING TELOMERASE ACTIVITY BY CONTACTING SAMPLE WITH PRIMERS, ONE HAVING LABELS AND SUBSTRATE FOR ENZYME, OTHER COMPLEMENTARY TO TELOMERIC REPEATS; ALLOWING ENZYME ACTIVITY; AMPLIFYING NUCLEIC ACIDS; DETECTING/MEASURING EMITTED ENERGY | INTERGEN COMPANY (US) | 2000-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190307904-A1 | MODIFIED WOUND DRESSINGS | MMP8, CD68, ELANE | KDM4E 2928/4885ALDH1A1 393/4885HPGD 279/4885 |
| US-20210275693-A1 | MODIFIED WOUND DRESSINGS | MMP8, CD68, ELANE | KDM4E 2928/4885ALDH1A1 393/4885HPGD 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.